Cytokinetics CEO Robert I. Blum disposes of $490,950 in common shares
Blum exercised options for 7,500 shares at $10.60 and sold 7,500 shares at $65.46 on Sept. 28, 2026.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.